1. Home
  2. VHI vs MRVI Comparison

VHI vs MRVI Comparison

Compare VHI & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VHI

Valhi Inc.

HOLD

Current Price

$11.70

Market Cap

370.5M

Sector

Industrials

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.36

Market Cap

449.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VHI
MRVI
Founded
1932
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
370.5M
449.6M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VHI
MRVI
Price
$11.70
$3.36
Analyst Decision
Sell
Buy
Analyst Count
1
7
Target Price
$12.00
$4.57
AVG Volume (30 Days)
28.1K
1.2M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
2.70%
N/A
EPS Growth
N/A
N/A
EPS
0.65
N/A
Revenue
$2,063,400,000.00
$192,435,000.00
Revenue This Year
$22.20
N/A
Revenue Next Year
$7.66
$9.04
P/E Ratio
$18.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.62
$1.67
52 Week High
$25.25
$6.21

Technical Indicators

Market Signals
Indicator
VHI
MRVI
Relative Strength Index (RSI) 41.75 45.70
Support Level $11.69 $3.21
Resistance Level $12.20 $3.59
Average True Range (ATR) 0.42 0.17
MACD -0.00 -0.04
Stochastic Oscillator 15.17 19.46

Price Performance

Historical Comparison
VHI
MRVI

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: